SCHEMBL9118979

SCHEMBL9118979

C[C@@H](O)c1ccc2cc(O)ccc2c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UGT2B7 P16662 1/20 0.67
CYP1A2 P05177 3/20 0.48
HSD17B10 Q99714 2/20 0.46
CYP2C9 P11712 2/20 0.46
ESR1 P03372 6/20 0.45
ESR2 Q92731 6/20 0.45
CYP3A4 P08684 2/20 0.45
TSHR P16473 2/20 0.45
HIF1A Q16665 2/20 0.45
ALOX15 P16050 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
PDCD1 Q15116 1/20 0.44
CD274 Q9NZQ7 1/20 0.44
ABL1 P00519 2/20 0.42
ABCB1 P08183 2/20 0.42
BCR P11274 2/20 0.42
CYP2D6 P10635 2/20 0.41
HSD17B1 P14061 1/20 0.41
CYP2B6 P20813 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15853505 1.00 UGT2B7 (0.67) UGT2B7CYP1A2HSD17B10CYP2C9ESR1
SCHEMBL5610446 0.89 UGT2B7 (0.82) UGT2B7CYP1A2CYP2C9TSHRHIF1A
SCHEMBL20398782 0.84 CYP1A2 (0.50) UGT2B7CYP1A2HSD17B10CYP2C9ESR1
SCHEMBL487450 0.84 CYP1A2 (0.56) UGT2B7CYP1A2HSD17B10CYP2C9ESR1
SCHEMBL10268972 0.82 CYP1A2 (0.52) UGT2B7CYP1A2HSD17B10CYP2C9ESR1
SCHEMBL27320155 0.81 CYP1A2 (0.46) UGT2B7CYP1A2HSD17B10CYP2C9ESR1
SCHEMBL13706061 0.81 CYP1A2 (0.46) UGT2B7CYP1A2HSD17B10CYP2C9ESR1
SCHEMBL13586940 0.81 CYP1A2 (0.46) UGT2B7CYP1A2HSD17B10CYP2C9ESR1
SCHEMBL12356631 0.80 ESR1 (0.50) UGT2B7CYP1A2HSD17B10CYP2C9ESR1
SCHEMBL110360 0.80 UGT2B7 (1.00) UGT2B7CYP1A2CYP3A4TSHRHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0398288-B1 Process for preparing optically active 2-arylalkanoic acids, in particular 2-arylpropionic acids PUETTER MEDICE CHEM PHARM (DE) 1995-10-18 EP disclosed
US-5380927-A Process for preparing optically active 2-aryl-alkanoic acids, in particular 2-aryl-propionic acids MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) 1995-01-10 US disclosed
US-5266723-A Process for the preparation of optically active 2-aryl-alkanoic acids, especially 2-aryl-propionic acids MEDICE, LTD., CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) 1993-11-30 US disclosed
CN-1050373-A Preparation optically-active 2-aryl-alkanoic, the particularly method of 2-arylpropionic acid PUETTER MEDICE CHEM PHARM (DE) 1991-04-03 CN disclosed